Avisol Capital Partners
Contributor since: 2017
Company: Avisol Capital Partners
Latest Articles
Your Daily Pharma Scoop: Biotech IPO Review - Replimune, Rubius And Allakos
AcelRX - The Military Angle That Could Boost Its Prospects
Your Daily Pharma Scoop: Advaxis Trial Cleared, Atossa Trial Proceeds, Amgen Resubmits NDA
Your Daily Pharma Scoop: Zogenix Zooms, Zynerba's Changing Fortunes, AbbVie Proceeds
Your Daily Pharma Scoop: ResTORbio Progresses, Roche Closer To Review, AbbVie Falters
Your Daily Pharma Scoop: Kamada Phase 3 Approved, Vivus Positive, IsoRay Down
Your Daily Pharma Scoop: IPO Review - Aptinyx Surges, Kezar Progresses, Neon Slumps
Your Daily Pharma Scoop: IsoRay Doubles, OncoCyte Zooms, Celgene Sluggish
Your Daily Pharma Scoop IPO Review: AUTL Zooms, STIM Surges, FTSV Slips
Your Daily Pharma Scoop: Biogen Rallies, AC Immune Goes Up, Not Everyone On Board With Biogen
Your Daily Pharma Scoop: Exelixis Publishes Positive Data, Stellar Trial Succeeds, Kalytera's Pre-IND Meet
Your Daily Pharma Scoop: Eagle Gets New Patent, Ocular Refiles NDA, Antibe's Phase 2b Data Announced
Your Daily Pharma Scoop: Review Of 3 More Stocks From The Biotech Boom IPO Week (18 - 22 June)
Your Daily Pharma Scoop: Redhill's New Patent, Nuvectra Slips, Teligent Gains
Your Daily Pharma Scoop: Spectrum Trial Proceeds, AzurRx Moves To Phase 3, Aptose Jumps
Your Daily Pharma Scoop: Gemphire Zooms, Trevena Succeeds, Arsanis Falters
Your Daily Pharma Scoop: FDA Approval For Array, Edge Zooms, Summit Nosedives
Your Daily Pharma Scoop: Glaukos And Achaogen Approvals, Puma Up On EU Prospects, FOLD Down
Your Daily Pharma Scoop: Heron Spikes, Ironwood Pharma Moves Ahead, Mesoblast Positive
Your Daily Pharma Scoop: Review Of 3 Stocks From The Biotech Boom IPO Week (18 - 22 June)
Your Daily Pharma Scoop: Reata Begins New Trial, CytoDyn Amends Protocol, Argenx Reports Positive Data
Your Daily Pharma Scoop: Anika Fails Trial, Kala's Upcoming Catalyst, Sarepta Surges
Your Daily Pharma Scoop: TG Therapeutics Phase 2 Results, Geron Positive, Agio In Phase 3
Your Daily Pharma Scoop: Secondary Offering Review, Week Of June 8-15, VSTM, SRRA
Your Daily Pharma Scoop: Selecta Bio Reports Positive, Acceleron And Atara Moves Up On Positive Data
Reata Pharma: This TPT Watchlist Stock Is Doing Pretty Well
Your Daily Pharma Scoop: Resverlogix Cleared For Trial, ViiV Positive Data, Eli Lilly Up
EyePoint: Shouldn't The Market Be More Enthusiastic?
Your Daily Pharma Scoop: Wright Receives PMA, Allergan And Corbus Report Positive
Your Daily Pharma Scoop: Sage On Accelerated Path, GenSight Positive Data, AstraZeneca And Eli Lilly Stumble
Your Daily Pharma Scoop: Tetraphase Positive Data, MediWound In Phase 3, Allergan Moves Up
Sangamo Therapeutics: Investability Outlook